Literature DB >> 22491282

Selecting antigens for cancer vaccines.

Francesca Avogadri, Jedd D Wolchok.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22491282     DOI： 10.1038/nbt.2174

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  10 in total

1.  gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.

Authors:  Douglas J Schwartzentruber; David H Lawson; Jon M Richards; Robert M Conry; Donald M Miller; Jonathan Treisman; Fawaz Gailani; Lee Riley; Kevin Conlon; Barbara Pockaj; Kari L Kendra; Richard L White; Rene Gonzalez; Timothy M Kuzel; Brendan Curti; Phillip D Leming; Eric D Whitman; Jai Balkissoon; Douglas S Reintgen; Howard Kaufman; Francesco M Marincola; Maria J Merino; Steven A Rosenberg; Peter Choyke; Don Vena; Patrick Hwu
Journal:  N Engl J Med       Date:  2011-06-02       Impact factor: 91.245

2.  Improved survival with ipilimumab in patients with metastatic melanoma.

Authors:  F Stephen Hodi; Steven J O'Day; David F McDermott; Robert W Weber; Jeffrey A Sosman; John B Haanen; Rene Gonzalez; Caroline Robert; Dirk Schadendorf; Jessica C Hassel; Wallace Akerley; Alfons J M van den Eertwegh; Jose Lutzky; Paul Lorigan; Julia M Vaubel; Gerald P Linette; David Hogg; Christian H Ottensmeier; Celeste Lebbé; Christian Peschel; Ian Quirt; Joseph I Clark; Jedd D Wolchok; Jeffrey S Weber; Jason Tian; Michael J Yellin; Geoffrey M Nichol; Axel Hoos; Walter J Urba
Journal:  N Engl J Med       Date:  2010-06-05       Impact factor: 91.245

3.  CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells.

Authors:  Sergio A Quezada; Karl S Peggs; Michael A Curran; James P Allison
Journal:  J Clin Invest       Date:  2006-06-15       Impact factor: 14.808

4.  Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity.

Authors:  C Naftzger; Y Takechi; H Kohda; I Hara; S Vijayasaradhi; A N Houghton
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

Review 5.  Cellular vaccine approaches.

Authors:  Dung T Le; Drew M Pardoll; Elizabeth M Jaffee
Journal:  Cancer J       Date:  2010 Jul-Aug       Impact factor: 3.360

6.  Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity.

Authors:  Francesca Avogadri; Taha Merghoub; Maureen F Maughan; Daniel Hirschhorn-Cymerman; John Morris; Erika Ritter; Robert Olmsted; Alan N Houghton; Jedd D Wolchok
Journal:  PLoS One       Date:  2010-09-10       Impact factor: 3.240

7.  Tumor-specific Th17-polarized cells eradicate large established melanoma.

Authors:  Pawel Muranski; Andrea Boni; Paul A Antony; Lydie Cassard; Kari R Irvine; Andrew Kaiser; Chrystal M Paulos; Douglas C Palmer; Christopher E Touloukian; Krzysztof Ptak; Luca Gattinoni; Claudia Wrzesinski; Christian S Hinrichs; Keith W Kerstann; Lionel Feigenbaum; Chi-Chao Chan; Nicholas P Restifo
Journal:  Blood       Date:  2008-03-19       Impact factor: 22.113

8.  Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma.

Authors:  Jose Pulido; Timothy Kottke; Jill Thompson; Feorillo Galivo; Phonphimon Wongthida; Rosa Maria Diaz; Diana Rommelfanger; Elizabeth Ilett; Larry Pease; Hardev Pandha; Kevin Harrington; Peter Selby; Alan Melcher; Richard Vile
Journal:  Nat Biotechnol       Date:  2012-03-18       Impact factor: 54.908

Review 9.  Novel cancer immunotherapy agents with survival benefit: recent successes and next steps.

Authors:  Padmanee Sharma; Klaus Wagner; Jedd D Wolchok; James P Allison
Journal:  Nat Rev Cancer       Date:  2011-10-24       Impact factor: 60.716

10.  Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors.

Authors:  Timothy Kottke; Fiona Errington; Jose Pulido; Feorillo Galivo; Jill Thompson; Phonphimon Wongthida; Rosa Maria Diaz; Heung Chong; Elizabeth Ilett; John Chester; Hardev Pandha; Kevin Harrington; Peter Selby; Alan Melcher; Richard Vile
Journal:  Nat Med       Date:  2011-06-19       Impact factor: 53.440
  10 in total
  2 in total

1.  Protein Expression Analysis of Melanocyte Differentiation Antigen TRP-2.

Authors:  Francesca Avogadri; Sacha Gnjatic; Jodie Tassello; Denise Frosina; Nicole Hanson; Megan Laudenbach; Erika Ritter; Taha Merghoub; Klaus J Busam; Achim A Jungbluth
Journal:  Am J Dermatopathol       Date:  2016-03       Impact factor: 1.533

2.  Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapse.

Authors:  Nicolas Boisgerault; Timothy Kottke; Jose Pulido; Jill Thompson; Rosa Maria Diaz; Diana Rommelfanger-Konkol; Addie Embry; Dyana Saenz; Eric Poeschla; Hardev Pandha; Kevin Harrington; Alan Melcher; Peter Selby; Richard Vile
Journal:  Mol Ther       Date:  2013-06-11       Impact factor: 11.454
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.